ETNB logo

89bio (ETNB) Company Overview

Profile

Full Name:

89bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 11, 2019

Indexes:

Not included

Description:

ETNB (89bio) is a biotechnology company focused on developing innovative treatments for liver and metabolic diseases. They aim to improve patient outcomes through advanced therapies, leveraging their expertise in drug development and research to address unmet medical needs in these areas.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 4, 25 Wolfe Research
Outperform
Jan 31, 25 UBS
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Jan 2, 25 Cantor Fitzgerald
Overweight
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Raymond James
Strong Buy
Sep 20, 24 Cantor Fitzgerald
Overweight
Aug 6, 24 Raymond James
Strong Buy
Aug 6, 24 RBC Capital
Sector Perform
Aug 6, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for 89bio?
  • Does 89bio pay dividends?
  • What sector is 89bio in?
  • What industry is 89bio in?
  • What country is 89bio based in?
  • When did 89bio go public?
  • Is 89bio in the S&P 500?
  • Is 89bio in the NASDAQ 100?
  • Is 89bio in the Dow Jones?
  • When was 89bio's last earnings report?
  • When does 89bio report earnings?
  • Should I buy 89bio stock now?

What is the ticker symbol for 89bio?

The ticker symbol for 89bio is NASDAQ:ETNB

Does 89bio pay dividends?

No, 89bio does not pay dividends

What sector is 89bio in?

89bio is in the Healthcare sector

What industry is 89bio in?

89bio is in the Biotechnology industry

What country is 89bio based in?

89bio is headquartered in United States

When did 89bio go public?

89bio's initial public offering (IPO) was on November 11, 2019

Is 89bio in the S&P 500?

No, 89bio is not included in the S&P 500 index

Is 89bio in the NASDAQ 100?

No, 89bio is not included in the NASDAQ 100 index

Is 89bio in the Dow Jones?

No, 89bio is not included in the Dow Jones index

When was 89bio's last earnings report?

89bio's most recent earnings report was on Nov 7, 2024

When does 89bio report earnings?

The next expected earnings date for 89bio is Feb 28, 2025

Should I buy 89bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions